These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
172 related articles for article (PubMed ID: 23543919)
1. Retrospective analysis of Steven Johnson syndrome and toxic epidermal necrolysis over a period of 5 years from northern Karnataka, India. Naveen KN; Pai VV; Rai V; Athanikar SB Indian J Pharmacol; 2013; 45(1):80-2. PubMed ID: 23543919 [TBL] [Abstract][Full Text] [Related]
2. Stevens Johnson syndrome, toxic epidermal necrolysis and SJS-TEN overlap: a retrospective study of causative drugs and clinical outcome. Sharma VK; Sethuraman G; Minz A Indian J Dermatol Venereol Leprol; 2008; 74(3):238-40. PubMed ID: 18583791 [TBL] [Abstract][Full Text] [Related]
3. Profile and pattern of Stevens-Johnson syndrome and toxic epidermal necrolysis in a general hospital in Singapore: treatment outcomes. Tan SK; Tay YK Acta Derm Venereol; 2012 Jan; 92(1):62-6. PubMed ID: 21710108 [TBL] [Abstract][Full Text] [Related]
4. Carbamazepine--the commonest cause of toxic epidermal necrolysis and Stevens-Johnson syndrome: a study of 7 years. Devi K; George S; Criton S; Suja V; Sridevi PK Indian J Dermatol Venereol Leprol; 2005; 71(5):325-8. PubMed ID: 16394456 [TBL] [Abstract][Full Text] [Related]
5. Retrospective study of 213 cases of Stevens-Johnson syndrome and toxic epidermal necrolysis from China. Yang L; Shou YH; Li F; Zhu XH; Yang YS; Xu JH Burns; 2020 Jun; 46(4):959-969. PubMed ID: 31898979 [TBL] [Abstract][Full Text] [Related]
6. Risk of Stevens-Johnson syndrome and toxic epidermal necrolysis during first weeks of antiepileptic therapy: a case-control study. Study Group of the International Case Control Study on Severe Cutaneous Adverse Reactions. Rzany B; Correia O; Kelly JP; Naldi L; Auquier A; Stern R Lancet; 1999 Jun; 353(9171):2190-4. PubMed ID: 10392983 [TBL] [Abstract][Full Text] [Related]
7. Lamotrigine Emerging as a Driver of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: An 8-Year Retrospective Study. Glahn JZ; Almeida MN; Kochen A; Noel O; Stogner V; Hsia HC; Savetamal A Burns; 2024 Nov; 50(8):2114-2123. PubMed ID: 39127578 [TBL] [Abstract][Full Text] [Related]
8. Drug-induced Stevens-Johnson syndrome (SJS), toxic epidermal necrolysis (TEN), and SJS-TEN overlap: a multicentric retrospective study. Barvaliya M; Sanmukhani J; Patel T; Paliwal N; Shah H; Tripathi C J Postgrad Med; 2011; 57(2):115-9. PubMed ID: 21654132 [TBL] [Abstract][Full Text] [Related]
9. A Rare Case Report of Toxic Epidermal Necrolysis Due to Ofloxacin. Vaghela JJ; Nimbark VN; Chavda BC; Mehta HH; Purohit BM Curr Drug Saf; 2018; 13(2):137-140. PubMed ID: 29506464 [TBL] [Abstract][Full Text] [Related]
10. A systematic review of the drug-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in Indian population. Patel TK; Barvaliya MJ; Sharma D; Tripathi C Indian J Dermatol Venereol Leprol; 2013; 79(3):389-98. PubMed ID: 23619444 [TBL] [Abstract][Full Text] [Related]
11. Stevens-Johnson syndrome and toxic epidermal necrolysis in sub-Saharan Africa: a multicentric study in four countries. Saka B; Barro-Traoré F; Atadokpédé FA; Kobangue L; Niamba PA; Adégbidi H; Yedomon HG; Traoré A; Pitché VP Int J Dermatol; 2013 May; 52(5):575-9. PubMed ID: 23330601 [TBL] [Abstract][Full Text] [Related]
12. Drug-induced Stevens-Johnson syndrome in Indian population: A multicentric retrospective analysis. Hirapara HN; Patel TK; Barvaliya MJ; Tripathi C Niger J Clin Pract; 2017 Aug; 20(8):978-983. PubMed ID: 28891542 [TBL] [Abstract][Full Text] [Related]
13. Treatment of toxic epidermal necrolysis by a multidisciplinary team. A review of literature and treatment results. Papp A; Sikora S; Evans M; Song D; Kirchhof M; Miliszewski M; Dutz J Burns; 2018 Jun; 44(4):807-815. PubMed ID: 29627131 [TBL] [Abstract][Full Text] [Related]
14. Differences between Stevens-Johnson syndrome versus toxic epidermal necrolysis. Nowsheen S; Lehman JS; El-Azhary RA Int J Dermatol; 2021 Jan; 60(1):53-59. PubMed ID: 33252832 [TBL] [Abstract][Full Text] [Related]
15. Stevens-Johnson syndrome and toxic epidermal necrolysis: a retrospective descriptive study. Carrasquillo OY; Santiago-Vazquez M; Cardona R; Cruz-Manzano M; Figueroa LD Int J Dermatol; 2019 Nov; 58(11):1293-1299. PubMed ID: 31166019 [TBL] [Abstract][Full Text] [Related]
16. Stevens-Johnson syndrome and toxic epidermal necrolysis - retrospective review of cases in a high complexity hospital in Brazil. Medeiros MP; Carvalho CHC; Santi CG; Avancini J Int J Dermatol; 2020 Feb; 59(2):191-196. PubMed ID: 31173347 [TBL] [Abstract][Full Text] [Related]
17. Nine years of a single referral center management of Stevens-Johnson syndrome and toxic epidermal necrolysis (Lyell's syndrome). Monteiro D; Egipto P; Barbosa J; Horta R; Amarante J; Silva P; Silva A Cutan Ocul Toxicol; 2017 Jun; 36(2):163-168. PubMed ID: 27487073 [TBL] [Abstract][Full Text] [Related]
18. Toxic epidermal necrolysis and Stevens-Johnson syndrome/toxic epidermal necrolysis overlap in pediatric patients with a focus on newer antiepileptic drugs: A 25-year retrospective study at a single tertiary care center. Gleghorn KL; Voigt C; Kelly B Pediatr Dermatol; 2021 Jul; 38(4):812-818. PubMed ID: 34060145 [TBL] [Abstract][Full Text] [Related]
19. Stevens-Johnson syndrome and toxic epidermal necrolysis due to anticonvulsants share certain clinical and laboratory features with drug-induced hypersensitivity syndrome, despite differences in cutaneous presentations. Teraki Y; Shibuya M; Izaki S Clin Exp Dermatol; 2010 Oct; 35(7):723-8. PubMed ID: 19874350 [TBL] [Abstract][Full Text] [Related]
20. Stevens-Johnson syndrome and toxic epidermal necrolysis in children: a review of the experience with paediatric patients in a university hospital. Ferrándiz-Pulido C; García-Fernández D; Domínguez-Sampedro P; García-Patos V J Eur Acad Dermatol Venereol; 2011 Oct; 25(10):1153-9. PubMed ID: 21198948 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]